Development of new basal insulin peglispro (LY2605541) ends in a disappointing result

Diabetol Int. 2016 Jan 29;7(1):16-17. doi: 10.1007/s13340-016-0255-1. eCollection 2016 Mar.
No abstract available

Publication types

  • Editorial